Skip to main content
HairCited

Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.

Wimolsiri Iamsumang, Kanchana Leerunyakul, Poonkiat Suchonwanit
Review Drug design, development and therapy 2020 66 sitasi
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D32184564'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Jenis Studi
Review
Intervensi
Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. None
Pembanding
Placebo
Arah Efek
Positive
Risiko Bias
Unclear

Abstract

The currently approved treatment for female pattern hair loss (FPHL) includes topical minoxidil administration; however, this treatment fails to achieve hair regrowth in some patients. Finasteride, a selective 5α-reductase inhibitor (5-ARI), may be considered as an alternative treatment. However, because of its potential teratogenic effects, clinical studies and use of finasteride for FPHL are limited. In this review, we aim to summarize the literature regarding the pharmacology, clinical efficacy, and adverse effects of oral finasteride for the treatment of FPHL and to provide novel therapeutic options including topical finasteride and dutasteride, a new generation 5-ARI, for the treatment of FPHL.

Used In Evidence Reviews

Similar Papers